학술논문
Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction
Document Type
Article
Author
Source
In: European Journal of Heart Failure . (European Journal of Heart Failure, November 2018, 20(11):1601-1610)
Subject
Language
English
ISSN
18790844
13889842
13889842